 liver transplantation treatment hepatic malignancies Twenty-eight patients orthotopic liver transplants malignant disease February December Preoperative diagnoses hepatocellular carcinoma cholangiocarcinoma primary hepatic tumors metastatic diseases liver Overall actuarial survivals months year years Long-term survival years patients recurrence rate patients months median months Hepatocellular carcinoma cholangiocarcinoma survival recurrence rates Specific prognostic factors survival recurrence results liver transplants long-term cure palliation malignant disease patient selection important outcome